Morgan Stanley Sticks to Its Buy Rating for ZJLD Group, Inc. (6979)
In a report released on May 29, Wilkins Tong from Morgan Stanley maintained a Buy rating on ZJLD Group, Inc. (6979 – Research Report), with a price target of HK$7.60.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Tong is a 2-star analyst with an average return of 17.7% and a 66.67% success rate.
ZJLD Group, Inc. has an analyst consensus of Hold.
The company has a one-year high of HK$10.52 and a one-year low of HK$5.56. Currently, ZJLD Group, Inc. has an average volume of 7.67M.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
34 minutes ago
- Business Insider
CFRA upgrades Dollar General (DG) to a Hold
In a report released today, Arun Sundaram from CFRA upgraded Dollar General (DG – Research Report) to a Hold, with a price target of $118.00. The company's shares closed today at $112.57. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sundaram is a 3-star analyst with an average return of 8.0% and a 63.16% success rate. Dollar General has an analyst consensus of Moderate Buy, with a price target consensus of $97.20, representing a -13.65% downside. In a report released today, Telsey Advisory also initiated coverage with a Hold rating on the stock with a $100.00 price target. Based on Dollar General's latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of $10.3 billion and a net profit of $191.22 million. In comparison, last year the company earned a revenue of $9.86 billion and had a net profit of $401.81 million Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DG in relation to earlier this year. Most recently, in April 2025, EMILY C TAYLOR, the EVP & Chief Merchandising Ofc of DG sold 809.00 shares for a total of $76,620.39.
Business Insider
34 minutes ago
- Business Insider
William Blair Reaffirms Their Buy Rating on LENZ Therapeutics (LENZ)
William Blair analyst Lachlan Hanbury Brown maintained a Buy rating on LENZ Therapeutics (LENZ – Research Report) today. The company's shares closed today at $29.77. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Hanbury Brown is a 3-star analyst with an average return of 6.2% and a 60.00% success rate. Hanbury Brown covers the Healthcare sector, focusing on stocks such as ARS Pharmaceuticals, Apellis Pharmaceuticals, and LENZ Therapeutics. Currently, the analyst consensus on LENZ Therapeutics is a Strong Buy with an average price target of $47.43.
Bloomberg
38 minutes ago
- Bloomberg
Action in Hong Kong Equity Markets Stirs Most Excitement in Years
Hong Kong's equity capital markets are seeing the most action in years, with multibillion dollar deals lifting the mood and fueling anticipation about more deals to come. 'I don't think we have seen this kind of excitement for Hong Kong and China for a long time,' said Cathy Zhang, head of Asia-Pacific equity capital markets at Morgan Stanley.
